首頁
Hester Biosciences

7月 2026Hester Biosciences的市場佔有率分析

hester biosciences limited is one of india's leading animal healthcare companies and is the second largest poultry vaccine manufacturer in the country.

金融 > 投資

域名hester.in

成立年份1987

僱員1001 - 5000

年度營收$25M - $50M

Hester Biosciences

Hester Biosciences（包含公司地區）

hester.in

查看更多網站流量與參與度資訊

Hester Biosciences截至 7月 2026 的總收入為 25M - 50M

Hester Biosciences 熱門網域產生的總收入

Hester Biosciences 熱門網域 3 年內的總收入

Hester Biosciences 熱門網域的總收入

hester.in25M - 50M

透過銷售情報查看更多內容

Hester Biosciences的熱門網域總造訪量

了解Hester Biosciences市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

hester.in4.8K

透過銷售情報查看更多內容

Hester Biosciences的熱門網域平均造訪時長

分析Hester Biosciences參與度指標。

過去 3 個月平均造訪時長

子公司細目

hester.in00:00:21

透過銷售情報查看更多內容

Hester Biosciences的熱門網域平均頁面瀏覽量

了解Hester Biosciences如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

hester.in1.43

透過銷售情報查看更多內容

Hester Biosciences按網域劃分的熱門競爭對手

7月 2026的熱門類似網站，依相似度排名

nmcbir.edu.np公司名| Contact-Us僱員1001 - 5000總部尼泊爾, Birganj年度營收--訪問總量2.5KN/A

使用的熱門技術Hester Biosciences

这些是Hester Biosciences顶级域名使用的行业网站技术

內容管理系統 (4)

WordPress

社群 (4)

Instagram

付費廣告 (2)

DoubleClick

轉換與分析 (2)

Google Analytics

更多技術

7

檢視所有

新聞與訊號來自Hester Biosciences

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Hester Biosciences Limited had earnings of $10.2M on Jun 1st '26.Hester Biosciences Ltd., one of India's leading animal health companies, manufacturing vaccines and health products, has reported consolidated net profit of Rs. 96.73 crore for the quarter ended June 2026, a rise of 459% Y-o-Y as compared to the net profit of Rs. 17.30 crore reported in Q1 FY26.

新聞Hester Biosciences Limited recognized as top small-cap companies with the highest EPS on Jan 1st '26.Synopsis: Five stocks including Hester Biosciences, Just Dial, and a few others emerged among the top small-cap companies with the highest EPS, backed by healthy growth in revenue, profitability, and earnings during FY26.

新聞Hester Biosciences Limited has earnings of $1.82M.Net profit of Hester Biosciences rose 1138.76% to Rs 15.98 crore in the quarter ended March 2026 as against Rs 1.29 crore during the previous quarter ended March 2025.